As a result, eight proteomic biomarkers were selected as the potential biomarkers of NPC with a sensitivity of 90.9% and specificity of 92.0% (Table 3), which was better than the diagnostic method using the EBV capsid antigen IgA antibodies (VCA-IgA). The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.